The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.50
Bid: 103.00
Ask: 108.00
Change: -0.50 (-0.47%)
Spread: 5.00 (4.854%)
Open: 105.50
High: 105.00
Low: 105.00
Prev. Close: 105.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

7 Apr 2020 07:00

RNS Number : 9745I
Intercede Group PLC
07 April 2020
 

 

 

 

7 April 2020

 

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

 

Trading Update

 

 

Intercede, the leading specialist in digital identity, credential management and secure mobility, is pleased to announce a continuing trend of improved operational and financial performance.

 

Subject to the completion of the year end audit, revenues for the year ended 31 March 2020 are expected to be in the region of £10.4m which is approximately 3% higher than the previous financial year. Whilst the level of growth is lower than market expectations, good progress has been made during the last year with all aspects of the business. The increased revenue primarily reflects the impact of follow on orders from existing customers and partners in the US, EMEA and SE Asia. The establishment and further development of partner relationships is critical for the Group's future growth prospects.

 

The combined effect of increased revenues and ongoing cost control is expected to result in increased profits that are substantially higher than market expectations and the previous financial year.

 

As at 31 March 2020, gross cash balances totalled £4.8m (2019: £3.2m).

 

It is too early to fully assess the impact of COVID-19 on Intercede's FY21 outlook. The Company has implemented its Business Continuity Plan and, with everyone now working from home, it is business as usual. A few delays were experienced with the receipt of orders and project upgrades that had been scheduled to take place in the last week of March, but they are all currently expected to proceed in the coming weeks.

 

Further detail will be provided within Intercede's final results which are expected to be published in June 2020.

 

 

 

 

ENQUIRIES

 

Intercede Group plc Tel. +44 (0)1455 558 111

Klaas van der Leest, Chief Executive

Andrew Walker, Finance Director

 

finnCap Tel. +44 (0)20 7220 0500

Stuart Andrews, Corporate Finance

Simon Hicks, Corporate Finance

 

 

About Intercede

 

Intercede is a cybersecurity company specialising in digital identities, derived credentials and access control, enabling digital trust in a mobile world.

Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

 

Our vision is to make the highest levels of cybersecurity available to organizations and consumers alike, solving complexity and scalability issues by managing high volumes of digital credentials.

 

We have been delivering trusted solutions to high profile customers for over 20 years. Our team of experts has deployed millions of identities to governments, most of the largest aerospace and defence corporations, and major financial services and healthcare organizations, as well as leading telecommunications, cloud services and information technology firms, providing industry-leading employee and customer credential management systems.

 

For more information visit: www.intercede.com

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSSAFWMESSELL
Date   Source Headline
25th May 20077:02 amRNSFinal Results
16th May 20077:01 amRNSPlacing
19th Apr 20075:25 pmRNSHolding(s) in Company
27th Mar 20077:02 amRNSTrading Update
19th Dec 200611:33 amRNSFurther US Government Win
18th Dec 20061:18 pmRNSDirector/PDMR Shareholding
14th Dec 20067:01 amRNSInterim Results
8th Dec 200611:43 amRNSTotal Voting Rights
27th Nov 20067:31 amRNSRe Gemalto Partnership in US
23rd Nov 200611:16 amRNSFurther US Government Wins
20th Nov 20067:02 amRNSNew US Government Contracts
16th Nov 20067:03 amRNSNew US Government Contract
23rd Oct 20067:01 amRNSContract Update
9th Oct 20067:01 amRNSUS Government Contract Win
1st Jun 20067:01 amRNSPreliminary Results
31st Mar 200612:00 pmRNSDirectorate Change
31st Mar 20067:02 amRNSTrading Statement
26th Jan 200610:38 amRNSFurther re OEM Agreement
20th Dec 200511:29 amRNSDirector/PDMR Shareholding
15th Dec 20057:00 amRNSInterim Results
12th Dec 200512:28 pmRNSRe New OEM Agreement
9th Dec 200512:47 pmRNSHolding(s) in Company
30th Nov 200510:42 amRNSFurther re OEM Agreement
21st Nov 20051:44 pmRNSFurther re Global OEM Licence
12th Sep 20057:00 amRNSRe: Global OEM Licence
13th Jun 20054:12 pmRNSHolding(s) in Company-Amend
25th May 200512:04 pmRNSHolding(s) in Company
24th May 20057:00 amRNSFinal Results
31st Mar 20057:00 amRNSTrading Statement
24th Feb 200512:48 pmRNSRe Contract
21st Jan 20059:11 amRNSRe Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.